Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 4
- 0 vs. Q3 2022
- Portfolio value
- $63.0M
- +$5.46M (+9.5%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | SPON ADS | 21,346,829 | $40.6M | 64.4% | +14,000,000+190.6% | Added | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 21,997,620 | $10.5M | 16.6% | 00.0% | Unchanged | – |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $9.98M | 15.8% | 00.0% | Unchanged | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $2.01M | 3.2% | 00.0% | Unchanged | History |